Joseph Truluck - 23 Feb 2022 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Chief Financial Officer
Signature
/s/ Joseph Truluck
Issuer symbol
ADIL
Transactions as of
23 Feb 2022
Transactions value $
$0
Form type
4
Filing time
25 Feb 2022, 14:02:28 UTC
Next filing
25 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Employee Stock Option Award $0 +100,000 $0.000000 100,000 23 Feb 2022 Common Stock 100,000 $2.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022.